Axogen, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stock Options (Details)

Stock Options (Details) (USD $)	12 Months Ended			0 Months Ended
Stock Options (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Sep. 27, 2011
Stock Option disclosures
Share-based compensation expense	$ 956,449	$ 671,887
Additional option disclosures
Total future stock compensation expense related to nonvested awards	2,120,000
Weighted average period of recognition of future stock compensation expense	2 years 2 months 9 days
Stock options
Stock option activity
Options, Outstanding at the beginning of the period (in shares)	1,969,492	1,799,991
Options, Granted (in shares)	935,750	261,000
Options, Forfeited (in shares)	(44,023)	(58,843)
Options, Exercised (in shares)	(117,401)	(32,656)
Options, Outstanding at the end of the period (in shares)	2,743,818	1,969,492	1,799,991
Options, Exercisable (in shares)	1,584,326
Weighted Average Exercise Price, Outstanding at the beginning of the period (in dollars per share)	$ 2.68	$ 2.54
Weighted Average Exercise Price, Granted (in dollars per share)	$ 3.57	$ 3.72
Weighted Average Exercise Price, Forfeited (in dollars per share)	$ (3.78)	$ (3.48)
Weighted Average Exercise Price, Exercised (in dollars per share)	$ (1.16)	$ (2.25)
Weighted Average Exercise Price, Outstanding at the end of the period (in dollars per share)	$ 3.03	$ 2.68	$ 2.54
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 2.78
Weighted Average Remaining Contractual Term, Outstanding	5 years 11 months 9 days	6 years 7 months 10 days	7 years 7 months 28 days
Weighted Average Remaining Contractual Term, Exercisable	5 years 6 months 26 days
Additional option disclosures
Average fair value of options granted	$ 3.57	$ 3.72
Intrinsic value of options exercised	266,000	48,000
Intrinsic value of options outstanding	1,535,000	3,571,000
Intrinsic value of options exercisable	$ 2,487,000	$ 1,278,000
Stock options \| Minimum
Stock Option disclosures
Option term		7 years
Stock options \| Maximum
Stock Option disclosures
Option term		10 years
Employee options \| Every six months
Stock Option disclosures
Vesting percentage		12.50%
Vesting period		4 years
Directors and officers options
Stock Option disclosures
Vesting period		0 years
Directors and officers options \| Quarterly
Stock Option disclosures
Vesting percentage		25.00%
Vesting period		1 year
Consultants options \| Minimum
Stock Option disclosures
Vesting period		3 years
Consultants options \| Maximum
Stock Option disclosures
Vesting period		10 years
AxoGen Plan
Stock Option disclosures
Number of additional shares of common stock authorized for issuance	750,000			2,300,000
Shares authorized for issuance	3,500,000